Drug name - Upneeq

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8357714 RVL PHARMS Compositions and methods for non-surgical treatment of ptosis Aug, 2031

(8 years from now)

US9867808 RVL PHARMS Compositions and methods for non-surgical treatment of Ptosis Aug, 2031

(8 years from now)

US10912765 RVL PHARMS Compositions and methods for non-surgical treatment of ptosis Aug, 2031

(8 years from now)

US10799481 RVL PHARMS Compositions and methods for treating ocular disorders Dec, 2039

(17 years from now)

US11103482 RVL PHARMS Oxymetazoline compositions Dec, 2039

(17 years from now)

US10814001 RVL PHARMS Oxymetazoline compositions Dec, 2039

(17 years from now)

US10898573 RVL PHARMS Oxymetazoline compositions Dec, 2039

(17 years from now)

US10940138 RVL PHARMS Compositions and methods for treating ocular disorders Dec, 2039

(17 years from now)

Drugs and Companies using OXYMETAZOLINE HYDROCHLORIDE ingredient

Treatment: Method of treating blepharoptosis

Dosage: SOLUTION/DROPS;OPHTHALMIC

More Information on Dosage
Strength Dosage Availability
0.1% SOLUTION/DROPS;OPHTHALMIC Prescription

availability in other generic markets.

Click on the highlighted region to filter.